AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
PetMed Express, Inc.
Video analysis: PETS
All videosNo video analysis for this stock yet. Request one from our team.
News: PETS
PetMeds Appoints Andrew Parry as Chief Technology Officer
DELRAY BEACH, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced the appointment of Andrew Parry as Chief Technology Officer, effective immediately. Parry will lead the Company's technology strategy, platform architecture and engineering execution across its e-commerce, pharmacy and enterprise systems.
Head-To-Head Contrast: PetMed Express (NASDAQ:PETS) versus Carvana (NYSE:CVNA)
Carvana (NYSE: CVNA - Get Free Report) and PetMed Express (NASDAQ: PETS - Get Free Report) are both consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Risk and Volatility Carvana has a beta of
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y
PETS' fiscal first-quarter 2027 sales decline year over year, but lower costs, stronger recurring sales and new partnerships offer signs of progress.
PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates
PetMed (PETS) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of $0.12. This compares to a loss of $0.34 per share a year ago.
PetMed Express, Inc. (PETS) Q1 2027 Earnings Call Prepared Remarks Transcript
PetMed Express, Inc. (PETS) Q1 2027 Earnings Call Prepared Remarks Transcript
PetMeds® Announces First Quarter Financial Results
DELRAY BEACH, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its first quarter ended June 30, 2026.
PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
DELRAY BEACH, Fla., July 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the first quarter fiscal year ended June 30, 2026, on Thursday, August 13, 2026 after market close. The Company will host a conference call and webcast to review these results at 4:30pm Eastern Time on the same day.
PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million
DELRAY BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that it has entered into a definitive agreement for a sale-leaseback transaction (“Transaction”) with an institutional real estate investor involving the Company's headquarters and distribution center buildings in Delray Beach, FL, for an aggregate purchase price of $37 million.
